上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1419Please respect copyright.PENANAoTkFC3dbjl
1419Please respect copyright.PENANAFc0JF2xIVE
上集:https://www.penana.com/article/4711251419Please respect copyright.PENANAG99MSMJitV
1419Please respect copyright.PENANAMMhEqqcjvX1419Please respect copyright.PENANA8UqsnIAURe
1419Please respect copyright.PENANAJKXnyIFWL5
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1419Please respect copyright.PENANA87n04H6teP
1419Please respect copyright.PENANASa3BsK1gyq
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1419Please respect copyright.PENANAtoTyx9Q3vP
1419Please respect copyright.PENANAjKFfb7GoND
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1419Please respect copyright.PENANAMrF5Xc3yYn
1419Please respect copyright.PENANAujm4diCe4P1419Please respect copyright.PENANAVv9B4BX5xH
1419Please respect copyright.PENANAO6YDCoQJUv
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1419Please respect copyright.PENANA7hgEjiF6CX
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1419Please respect copyright.PENANA0gXVaeMHV9
1419Please respect copyright.PENANAoH2yoGbtgB
忘記甚麼是Neoantigen的話,可重溫上一集。1419Please respect copyright.PENANA84XHPii2gq
1419Please respect copyright.PENANA28yhfuak38
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1419Please respect copyright.PENANAigHoDvtr3Z
1419Please respect copyright.PENANAibyHovTKO3
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1419Please respect copyright.PENANArHvEzubCGN
1419Please respect copyright.PENANA1pHPjhp0rE1419Please respect copyright.PENANAzyFgpk8rJq
1419Please respect copyright.PENANAJFgxT1sB5q
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1419Please respect copyright.PENANAo3HtOhLBHM
1419Please respect copyright.PENANAaDv9wQ89HP
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1419Please respect copyright.PENANAofn2lXCJjb
1419Please respect copyright.PENANAfIe6e1x7YE
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1419Please respect copyright.PENANAWo4KZDKxsH1419Please respect copyright.PENANAk24nL12HcC
1419Please respect copyright.PENANArXo0LQ9b8T
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1419Please respect copyright.PENANAMJFirjdFym
1419Please respect copyright.PENANAwqEO3iSJPd
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1419Please respect copyright.PENANAV7T73OIYlg1419Please respect copyright.PENANAGTqIbsjHy6
1419Please respect copyright.PENANAVXhEF2Q7Ea
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1419Please respect copyright.PENANA3w3M5EhYno
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1419Please respect copyright.PENANA9ueVqn90Za
1419Please respect copyright.PENANAYtqxANwilH
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1419Please respect copyright.PENANAhDohgyRIyp
1419Please respect copyright.PENANATXs3lS6Sxe
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1419Please respect copyright.PENANA255foGMcmN
1419Please respect copyright.PENANA3coO3RjwPh
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1419Please respect copyright.PENANAhdrik6qrjP
1419Please respect copyright.PENANAUEdMcUO2dk
1419Please respect copyright.PENANA5cCLFDgF2B
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1419Please respect copyright.PENANAMDUOmBvvHa
1419Please respect copyright.PENANASTKtVQ1ErR
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1419Please respect copyright.PENANAMUuHcPtaXI
1419Please respect copyright.PENANA0e6hNiCjLy
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1419Please respect copyright.PENANAqZDklCIT8B
1419Please respect copyright.PENANA8Znah2k4Dm
Link:1419Please respect copyright.PENANAQ7OkcVH9zI
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1419Please respect copyright.PENANA04yUyUJnMs
1419Please respect copyright.PENANAkO0l8dWFhT
1419Please respect copyright.PENANACsRDUOO2n7
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1419Please respect copyright.PENANAqU8KpGQuFP